Fortress Biotech, Inc. (FBIO)
NASDAQ: FBIO · Real-Time Price · USD
1.720
-0.020 (-1.15%)
Dec 20, 2024, 4:00 PM EST - Market closed
Fortress Biotech Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Fortress Biotech stock have an average target of 18, with a low estimate of 10 and a high estimate of 26. The average target predicts an increase of 946.51% from the current stock price of 1.72.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 18, 2024.
Analyst Ratings
The average analyst rating for FBIO stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $24 → $26 | Strong Buy | Maintains | $24 → $26 | +1,411.63% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $24 | Strong Buy | Reiterates | $24 | +1,295.35% | Jul 19, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 20, 2024 |
| Roth MKM | Roth MKM | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +481.40% | May 16, 2024 |
| Roth MKM | Roth MKM | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +481.40% | Mar 15, 2024 |
Financial Forecast
Revenue This Year
59.29M
from 84.51M
Decreased by -29.84%
Revenue Next Year
139.16M
from 59.29M
Increased by 134.70%
EPS This Year
-3.48
from -8.47
EPS Next Year
-1.57
from -3.48
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 62.4M | 189.6M | 251.7M |
| Avg | 59.3M | 139.2M | 244.5M |
| Low | 55.7M | 90.5M | 234.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -26.2% | 219.7% | 80.8% |
| Avg | -29.8% | 134.7% | 75.7% |
| Low | -34.1% | 52.6% | 68.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -3.44 | -0.91 | -0.50 |
| Avg | -3.48 | -1.57 | -0.49 |
| Low | -3.48 | -2.16 | -0.47 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.